A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors
NCT06873542
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
DC05F01
Sponsor
Heronova Pharmaceuticals